Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by 180 Life Sciences Corp. effective as of February 9, 2024, at 11:00 A.M. The effectiveness of this form indicates that the company has met the necessary SEC requirements to proceed with the registration of its securities for sale to the public. The SEC's notice of effectiveness is a standard procedure for companies looking to issue new shares and is a significant step towards the company's efforts to raise capital through public investment.
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by 180 Life Sciences Corp. effective as of February 9, 2024, at 11:00 A.M. The effectiveness of this form indicates that the company has met the necessary SEC requirements to proceed with the registration of its securities for sale to the public. The SEC's notice of effectiveness is a standard procedure for companies looking to issue new shares and is a significant step towards the company's efforts to raise capital through public investment.
美国证券交易委员会（SEC）宣布，180 Life Sciences Corp. 提交的S-1表格自2024年2月9日上午11点起生效。该表格的有效性表明该公司已满足美国证券交易委员会的必要要求，可以注册向公众出售的证券。美国证券交易委员会的生效通知是希望发行新股的公司的标准程序，也是该公司朝着通过公共投资筹集资金的努力迈出的重要一步。
美国证券交易委员会（SEC）宣布，180 Life Sciences Corp. 提交的S-1表格自2024年2月9日上午11点起生效。该表格的有效性表明该公司已满足美国证券交易委员会的必要要求，可以注册向公众出售的证券。美国证券交易委员会的生效通知是希望发行新股的公司的标准程序，也是该公司朝着通过公共投资筹集资金的努力迈出的重要一步。
有用
没用
